🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison effectiveness two methods revascularization of the superficial f...
Status
Unknown
Location
Federal State Institution Academician E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rusmedtechnology
Start Date
2017-01
Trial ID
NCT03142347
Treatments Being Tested
The purpose of the study is to use a novel treatment approach, the artifici...
Status
Unknown
Location
Southampton Children's Hospital
Start Date
2017-01
Trial ID
NCT02871089
Treatments Being Tested
The study will be conducted in crossover trial, with two 72-hour hospitaliz...
Status
Completed
Location
Hôpital Jean Minjoz
Start Date
2015-11
Trial ID
NCT02627911
Treatments Being Tested
Closed-loop strategy is composed of three components: glucose sensor to rea...
Status
Withdrawn
Location
Institut de recherches cliniques de Montréal
Start Date
2018-03
Trial ID
NCT02488616
The purpose of this study is to evaluate the safety and efficacy of the Sal...
Status
Completed
Location
Hope Research Institute
Start Date
2017-01-27
Trial ID
NCT02924129
Treatments Being Tested
The purpose of this study is to explore the functional and physiological ef...
Status
Completed
Location
Department of Neurology, Wake Forest School of Medicine
Start Date
2011-08-23
Trial ID
NCT02709369
Treatments Being Tested
The purpose of this study is to test a new way to treat Parkinson's disease...
Status
Recruiting
Location
University of California San Francisco
Start Date
2026-04-09
Trial ID
NCT07398157
Comparison of two methods for revascularization of the superficial femoral ...
Status
Unknown
Location
Federal State Institution Academician E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rusmedtechnology
Start Date
2016-01
Trial ID
NCT02948166
Treatments Being Tested